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Abstract
Background: Over 100 million people worldwide suffer from birch pollen allergy. Bet 
v 1 has been identified as the major birch pollen allergen. However, the molecular 
mechanisms of birch allergic sensitization, including the roles of Bet v 1 and other 
components of the birch pollen extract, remain incompletely understood. Here, we 
examined how known birch pollen–derived molecules influence the endolysosomal 
processing of Bet v 1, thereby shaping its allergenicity.
Methods: We analyzed the biochemical and immunological interaction of ligands 
with Bet v 1. We then investigated the proteolytic processing of Bet v 1 by endoso‐
mal extracts in the presence and absence of ligands, followed by a detailed kinetic 
analysis of Bet v 1 processing by individual endolysosomal proteases as well as the 
T‐cell epitope presentation in BMDCs.
Results: We identified E1 phytoprostanes as novel Bet v 1 ligands. Pollen‐derived ligands 
enhanced the proteolytic resistance of Bet v 1, affecting degradation kinetics and preferen‐
tial cleavage sites of the endolysosomal proteases cathepsin S and legumain. E1 phytopros‐
tanes exhibited a dual role by stabilizing Bet v 1 and inhibiting cathepsin protease activity.
Conclusion: Bet v 1 can serve as a transporter of pollen‐derived, bioactive com‐
pounds. When carried to the endolysosome, such compounds can modulate the 
proteolytic activity, including its processing by cysteine cathepsins. We unveil a para‐
digm shift from an allergen‐centered view to a more systemic view that includes the 
host endolysosomal enzymes.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2019 The Authors. Allergy published by John Wiley & Sons Ltd
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1  | INTRODUC TION
An allergic response is a two‐step process, involving an initial sen‐
sitization step characterized by a pronounced Th2 polarization and 
followed by an acute antibody recognition step.1 While the latter 
can be triggered by isolated allergen molecules alone, such as the 
primary birch pollen allergen Bet_v_1, the initial sensitization pro‐
cess is more complex. We recently found that, in the case of birch 
(Betula verrucosa) pollen allergy, Th2 polarization is not driven by its 
major allergen Bet_v_1.2 This observation makes the role of Bet_v_1 
as a major allergen even more intriguing.3,4 In this context, Bet_v_1’s 
ability to function as a carrier or storage protein for a wide variety of 
natural hydrophobic ligands has been discussed.5 Indeed, several al‐
lergens have been investigated concerning their lipid‐binding prop‐
erties as a determinant of allergenicity.6
Three major groups of compounds have been proposed to 
interact or cooperate with Bet_v_1, two of which are pollen‐de‐
rived: (a) flavonoids, (b) phytohormones, and (c) microbe‐derived 
Toll‐like receptor (TLR) agonists. In a previous study, the glyco‐
sylated flavonoid quercetin 3‐O‐sophoroside (Q3OS) was found 
to co‐purify with Bet_v_1 from pollen and therefore reported as 
a physiological Bet_v_1 ligand.7 Phytohormones, including phyto‐
prostanes and brassinosteroids, are low‐molecular‐weight com‐
pounds present in pollen extract. While the ability of Bet_v_1 
to bind brassinosteroids has been demonstrated,8 physical 
interactions with Bet_v_1 have not yet been reported for phyto‐
prostanes. Phytoprostanes like E1 (PPE1) are functionally related 
to mammalian prostaglandins and possess Th2‐skewing activity, 
making them of potential interest as a sensitization mechanism.9 
Other ligands of interest include deoxycholate (DOC), a second‐
ary bile acid generated as a microbial metabolic byproduct that is 
structurally similar to brassinosteroids10 and serves as an estab‐
lished model ligand for Bet_v_1.10,11 In addition, immunomodula‐
tory microbial compounds (such as the TLR2 and NLRP6 agonist 
lipoteichoic acid, LTA, and the endotoxin lipopolysaccharide, LPS) 
have been proposed to interact with Bet_v_1.6,12‐15
Bet_v_1 ligands have been proposed either to exhibit direct im‐
munomodulatory functions16 or to stabilize the Bet_v_1 conformation 
indirectly, which could change its immunogenicity and allergenicity 
by influencing its processing in the endolysosome.17,18 Among endo‐
lysosomal proteases, the large family of cathepsins, most of which are 
cysteine proteases belonging to the papain family, plays an important 
role in proteolytic activity.19 Only a few other proteases have been 
shown to be relevant in antigen processing, including the cysteine 
protease legumain.20 As such, the endosomal degradation of Bet_v_1 
can be modeled by microsomal extracts and reproduced using puri‐
fied extracts, particularly cathepsin S and legumain.21
In this study, we biochemically and immunologically dissected the 
interactions of recombinant Bet_v_1.0101 (termed Bet_v_1 in the fol‐
lowing), the most abundant isoform of Bet_v_1 present at approximately 
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50%‐70%,22 with several ligands, including Q3OS, PPE1, and DOC. 
Remarkably, PPE1 was not only retained by Bet_v_1, but also inhibited the 
cysteine cathepsins in the endolysosome. We discuss the implications of 
these new findings for our understanding of pollen‐derived allergy.
2  | MATERIAL S AND METHODS
A detailed description of the methods is provided in the Appendix S1.
2.1 | Expression, purification, and physicochemical 
characterization of recombinant Bet_v_1
Production of recombinant Bet_v_1.0101 and monitoring of endotoxin 
contamination (<0.3 ng/mL) were performed as previously described.3,11
2.2 | Investigated compounds and Bet_v_1 ligands
DOC, 8‐anilinonaphthalene‐1‐sulfonic acid (ANS), naringenin, LTA 
from Staphylococcus aureus, and LPS from Escherichia coli O111:B4 
were purchased from Sigma‐Aldrich, Inc; Kdo2‐Lipid A (Kdo2) from 
Adipogen, Inc or Avanti Polar Lipids, Inc; and quercetin 3‐O‐sophoro‐
side (Q3OS) from Haihang Industry Co., Ltd. PPE1, B1‐phytoprostanes 
(PPB1), F1‐phytoprostanes (PPF1), and an isomeric mixture consisting 
of B1‐, E1‐, and F1‐phytoprostanes (PPmix) were produced by autoxi‐
dation of α‐linolenic acid, as described elsewhere.23 Type I or/and 
type II phytoprostanes were used, as indicated in Figure 4C. Unless 
otherwise stated, Bet_v_1 was mixed with each of the six ligands in a 
1:10 molar ratio and incubated either overnight at 4°C or for 2 hours 
at room temperature. A1‐phytoprostanes (PPA1) were purchased 
from Cayman Chemicals and dried and dissolved in DMSO.
2.3 | Protein‐ligand interaction
Surface acoustic wave (SAW) technology and NMR spectroscopy were 
used to observe the interaction of Bet_v_1 with the selected com‐
pounds, including determination of the dissociation constant (Kd). The 
influence of ligand binding on the secondary structure elements and 
the thermal stability of Bet_v_1 was monitored using circular dichroism 
(CD, JASCO J‐815 spectropolarimeter, Jasco) and Fourier transform in‐
frared (FTIR) spectroscopy (Tensor II FTIR system, Bruker Optics Inc). 
A detailed description of these methods is available (Appendix S1).
2.4 | Immunological assays
The ability of ligand‐loaded Bet_v_1 to induce IgE‐antigen cross‐
linking and basophil degranulation was assessed by mediator‐re‐
lease assays using rat basophil (RBL‐2H3) cells, transfected with 
the human high‐affinity IgE receptor (FcεRI), as previously de‐
scribed.2,24 In vitro uptake of labeled Bet_v_1 was performed using 
CD11c+ murine bone marrow–derived dendritic cells (BMDCs). The 
maturation of human monocyte‐derived dendritic cells (moDCs) 
was analyzed as previously described.2 T‐cell proliferation assays 
using CD4+ T‐cell hybridomas were performed as previously de‐
scribed.17 A detailed description of the in vitro assays is available 
(Appendix S1).
2.5 | In vitro simulation of endolysosomal 
degradation using microsomes and individual 
endolysosomal proteases
The endolysosomal degradation assay was performed with li‐
gand‐bound (either DOC, PPE1, or Q3OS in 10× molar excess) and 
Bet_v_1 without ligands (apo‐Bet_v_1) as previously described.21 
Recombinant human cathepsin S and human legumain were used in 
proteolytic degradation assays. Experimental details are described 
in the Appendix S1.
2.6 | Enzymatic activity assays
To evaluate the influence of Bet_v_1 ligands on cathepsin S and 
legumain activities, 10 nmol/L of protease was incubated with 
100 µmol/L of ligand (unless otherwise stated) and 50 µmol/L of 
fluorogenic substrate in digestion buffer (0.1 mol/L sodium acetate 
pH 5.0, 0.1 mol/L sodium chloride, 5 mmol/L EDTA, and 2 mmol/L 
DTT), as described in the Appendix S1. The effect of birch pollen 
extract (BPE) (20‐200 µg/mL) on the cathepsin S and legumain ac‐
tivities was assessed in parallel. The inhibitory effect of PPE1 was 
assessed by replacing DTT with 0.5 mmol/L TCEP. Activities of re‐
combinant rat cathepsin B (provided by Dr Lukas Mach) and papain 
(Merck) at 10 nmol/L were assayed using Z‐FR‐AMC (Bachem) as a 
fluorogenic substrate.
3  | RESULTS
3.1 | Bet_v_1 interacts with high affinity with 
pollen‐derived PPE1 and Q3OS and with the 
brassinosteroid‐like compound DOC, but not with 
LTA or LPS
To assess the interactions between Bet_v_1 and Q3OS, DOC, PPE1, 
LTA, or LPS, we determined the dissociation constants (Kd) using 
SAW binding assays (Table 1, Figure S1), a more quantitative ap‐
proach than previously described qualitative assays.11,25 In addition, 
the LPS‐substructure Kdo2‐Lipid A (Kdo2) was used for binding stud‐
ies, due to its more homogenous structure but similar immune stimu‐
latory activity when compared to native LPS.
As a reference ligand, the binding of ANS to Bet_v_1 was deter‐
mined (Kd of 32.7 µmol/L) which is similar to previously published 
Kd values (18.5 µmol/L).
26 The two pollen‐derived components, 
Q3OS and PPE1, exhibited high binding affinities with Kd = 1.5 
and 0.5 µmol/L, respectively. The bacterial TLR agonists, LTA 
(199.8 µmol/L) and LPS (185.0 µmol/L), and the model substances, 
DOC (58.8 µmol/L) and Kdo2 (379.8 µmol/L), demonstrated higher 
Kd values, indicating lower binding affinities. For the phytopros‐
tane derivatives, PPB1 and PPF1, as well as for a physiologically 
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relevant isomeric mixture consisting of B1‐, E1‐, and F1‐phytopros‐
tanes (PPmix), we observed dissociation constants of 1.0, 2.4, and 
1.2 µmol/L, respectively.
To validate the interactions determined by SAW, we used 
NMR spectroscopy to test the specific binding of PPE1, LTA, LPS, 
and Kdo2 to Bet_v_1 (Table 1, Figure S2). Substantial differences 
between the1H‐15N HSQC spectra of 15N‐labeled Bet_v_1 in the 
absence and presence of PPE1 confirmed that the allergen specif‐
ically binds PPE1. The Kd was consistent with a low to sub‐µmol/
Laffinity, but intermediate exchange and a poor signal‐to‐noise 
ratio prevented direct measurement. The commercially available 
PPA1 was used as a substitute for PPE1 to identify the phytopros‐
tane binding site(s). No significant interactions were observed for 
LTA, LPS, or Kdo2, indicating that these bacterial compounds do 
not specifically bind to Bet_v_1, consistent with LPS pull‐down 
assays using Bet_v_1 and biotinylated LPS immobilized on Strep‐
Tactin Sepharose beads (Figure S3).
Moreover, using CD and FTIR spectroscopy we observed 
an increased melting point (Tm) of approximately 4°C and nearly 
7°C for Bet_v_1 bound to DOC and PPE1, respectively (Table 2). 
Bet_v_1Binding of DOC, Q3OS or PPE1 to Bet_v_1 did not signifi‐
cantly alter its secondary structure content (Figure S4).
3.2 | Ligand binding to Bet_v_1 does not affect 
basophil degranulation or the activation of 
dendritic cells
We next set out to test for effects on Bet_v_1‐complexes on differ‐
ent stages of the allergic immune response. Antigen uptake was as‐
sessed by uptake of pHrodo™ Red‐labeled Bet_v_1, with or without 
ligands (Figure S5A), and subsequent FACS analysis. Sensitizing po‐
tential was assessed on the level of dendritic cells by flow cytometric 
analysis of maturation marker expression and by determination of Th 
polarization‐associated cytokines in cell culture supernatants (Figure 
S5B and C). IgE cross‐linking by Bet_v_1‐complexes was assessed by 
RBL assay (Figure S6). None of the above described readouts was 
influenced by the presence of plant‐derived Bet_v_1 ligands (Q3OS, 
PPE1, and DOC).
3.3 | Ligand interactions with Bet_v_1 influence its 
lysosomal processing
Given the relevance of conformational stability and proteolytic re‐
sistance for MHCII presentation,27 we prepared endosomal extracts 
to assess the resistance of Bet_v_1 in complex with the model ligands 
toward endolysosomal proteases over 48 hours. Densitometric 
analysis of SDS‐PAGE (Figure 1A and B) revealed an enhanced pro‐
teolytic stability of Bet_v_1 in the presence of PPE1 and DOC. By 
contrast, Q3OS had only a weakly stabilizing effect over the first 
12 hours. This observation correlated with our thermal stability data.
As the lysosomal resistance of allergens correlates with the 
quality and quantity of the ensuing immune response,17 we an‐
alyzed the peptides generated after 12‐hours incubation with 
endolysosomal proteases (Figure 1C). The binding of Q3OS re‐
sulted in a 2‐fold higher diversity of peptides within the differ‐
ent peptide clusters than with the apo form of Bet_v_1, whereas 
the resulting Bet_v_1 peptide diversity was reduced upon binding 
of PPE1 and DOC (to 53.9% and 69.7%, respectively). In a semi‐
quantitative approach, the generated peptides were grouped into 
seven main core clusters with their relative abundances shown 
(Figure 1D). The rate of core peptide production and/or elimina‐
tion was affected by the presence of ligands. In the presence of 
PPE1 or DOC, Bet_v_1 processing preferentially accumulated the 
two N‐terminal cluster peptides. Bet_v_1 in complex with Q3OS or 
DOC showed an altered pattern of proteolytic processing, which 
resulted in a more efficient generation of the immunodominant 
T‐cell epitope, as indicated by the number of identified peptides 
(gray box in Figure 1C). Bet_v_1Together, these data show that 
both the quantity and the quality of the peptide pool available for 
MHCII presentation are affected by the ligands.
3.4 | Modeling the microsomal processing of 
Bet_v_1 by cathepsin S and legumain reveals the 
mechanistic basis of attenuated degradation
Since an endosomal extract is a complex mixture of various hy‐
drolases, we aimed to break down the complexity of the assay 
by identifying key proteases of the microsomal extracts and fur‐
ther analyzing the influence of ligand binding to Bet_v_1 on their 
processing capability. Based on previously described enzymatic 
data,21,28 we tested the microsomal fraction for enzymatic activ‐
ity toward substrates of cathepsin and legumain, two prominent 
endolysosomal cysteine protease families with complementary 
substrate preferences and orthogonal catalytic mechanisms.29 
Consistent with the literature,30 we detected both cathepsin‐like 
and legumain‐like enzymatic activities in microsomal extracts, and 
these activities were specifically inhibited by cathepsin S/B and 
legumain inhibitors (Figure S7).
Consequently, we tested whether cathepsin S or legumain qual‐
itatively reproduced the endolysosomal degradation kinetics of apo 
and ligand‐bound Bet_v_1. Indeed, processing by the individual pro‐
teases was strongly retarded by DOC, and, in the case of cathepsin 
S, also by PPE1. Other reported Bet_v_1 ligands
11 had either a minor 
(Naringenin) or no detectable (PPB1, ANS) effect on its proteolytic 
resistance. SDS, which also binds Bet_v_1,31 significantly accelerated 
its degradation by both proteases (Figure 3A and B). By contrast, 
SDS reduced the cleavage of fluorogenic substrates by cathepsin S 
(Figure 3A). These observations can be reconciled by assuming that 
the binding of SDS to Bet_v_1 exposes additional vulnerable sites to 
the protease.
The majority of the peptide clusters were generated using 
cathepsin S alone; however, several cleavage sites after asparagine 
were only reproduced using legumain, as no other known protease 
exhibits an asparaginyl‐peptidase activity,32 particularly relevant 
for the production of C‐terminal peptide clusters (Figure 1C, Figure 
S8). To understand how the pattern and the kinetics of Bet_v_1 
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processing were affected by the presence of ligands, we analyzed 
the relative abundance of the resulting peptides. The presence of 
ligands mostly affected the frequency of cleavages at certain sites 
within Bet_v_1, but rarely generated new cleavage sites not present 
in the apo form. PPE1 induced prominent changes in relative prefer‐
ence of the Bet_v_1 cleavage sites. Although other ligands affected 
the cleavage pattern as well, PPE1 was used to illustrate the effect of 
ligand binding on the generation of cleavage sites: Upon incubation 
with cathepsin S, preferential cleavage was observed after Phe20, 
Lys21, and in the C‐terminal region; upon incubation with legumain, 
cleavage frequency after Asn120 and Asp157 strongly increased 
(Figure 2C). Overall, this analysis shows that the relative abundance 
of peptides available for MHC presentation is strongly affected by 
the presence of ligands.
3.5 | Birch pollen extract reduces cathepsin activity 
in a dose‐dependent manner
We wondered whether the observed (de)stabilizing effects of the 
ligands were caused exclusively by the interaction with Bet_v_1. 
Therefore, we tested whether the ligands affected protease activ‐
ity toward small peptidic substrates. Surprisingly, PPE1 specifically 
inhibited cathepsin S, but not legumain (Figure 3A).
Since approximately 0.5 µg of PPE1 is present in 1 mg of birch 
pollen–extracted protein,9 we can expect about 150 pmol PPE1 in 
100 µg of pollen‐extracted protein per mL, that is, 150 nM PPE1, in 
agreement with the reported concentration range.33 Although the 
extraction will come with significant losses, and only type II of PPE1 is 
an active inhibitor, we hypothesized that BPE at corresponding con‐
centrations should also attenuate proteolytic activity. Therefore, we 
investigated the influence of BPE on cathepsin S and legumain activity 
(Figure 3B). In contrast to the marginal effects on legumain activity, a 
dose‐dependent inhibition of cathepsin S was observed. Bet_v_1 at 
the highest concentration (200 µg/mL) was used to exclude possible 
substrate competition effects. These data suggest that the BPE‐medi‐
ated cathepsin S inhibition may be partially caused by PPE1.
3.6 | PPE1 inhibits lysosomal cathepsins by 
blocking their catalytic cysteine
To further investigate the mechanism of PPE1‐mediated inhibition, 
we analyzed other proteases and found PPE1‐mediated inhibition 
of the papain‐like protease family, such as cysteine cathepsins. By 
contrast, legumain, which belongs to a different protease class, was 
not inhibited (Figure 4A). Importantly, the structurally similar PPB1 
and PPF1 did not inhibit cathepsin S activity (Figure 4B and C). We 
wanted to examine whether PPE1 exerts its effect by reacting with 
the nucleophilic cysteine thiol in the active site, a characteristic for 
this protease class. Therefore, we compared the effect of two reduc‐
ing agents, (a) the thiol‐containing DTT and (b) tris(2‐carboxyethyl)
phosphine (TCEP), which lacks any thiol groups. Cathepsin S activity 
was completely abolished by PPE1 in the presence of TCEP, but not 
in the presence of DTT (Figure 4D, Figure S9). This differential effect 
can be understood by DTT thiols competing for the reactive site on 
TA B L E  1   Binding affinity (Kd) of Bet_v_1 to the selected compounds as determined by SAW interaction studies and binding confirmation 
by NMR spectroscopy
 Compound MW [Da] Kd [µmol/L] SD [µmol/L] NMR [µmol/L]
Pollen‐derived compounds Q3OS 626.5 1.5 ±0.1 [7]
PPmix  1.2 ±0.1 n.d.
PPB1 308.4 1.0 ±0.4 n.d.
PPF1 328.4 2.4 ±0.5 n.d.
PPE1 356.5 0.5 ±0.1 0.1‐1
PPA1 308.4 n.d. n.d. 0.1‐1
Model compounds mimicking essen‐
tial binding groups
DOC 414.6 58.8 ±24.3 [11]
ANS 299.34 32.7 ±0.3 [11]
Bacteria‐derived compounds LTA 4000‐8000 199.8 ±55.7 No significant interactions
LPS 10 000‐20 000 185.0 ±123.1 No significant interactions
Kdo2 2306.8 379.8 ±62.8 No significant interactions
Ligand Tm CD SD CD Tm FTIR SD FTIR ΔCD ΔFTIR
‐ 63.68 ±0.06 63.38 ±2.24   
Q3OS 64.04 ±0.10 65.26 ±1.77 +0.36 +1.88
DOC 67.44 ±0.58 66.6 ±4.36 +3.81 +3.22
PPE1 70.62 ±0.15 69.31 ±0.05 +6.94 +5.93
Abbreviations: CD, circular dichroism; FTIR, Fourier transform infrared spectroscopy; Tm, melting 
point; SD, Standard deviation.
TA B L E  2   Influence of ligand 
interaction on thermal stability of Bet_v_1 
(values in °C)
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the PPE1 inhibitor. By contrast, no inhibitory effect on legumain by 
PPE1 was found. In the absence of PPE1, we found high cathepsin 
S activity toward a fluorogenic substrate in the presence of both 
TCEP and DTT (Figure 4D, Figure S9). The slightly stronger activ‐
ity‐enhancing effect of TCEP vs DTT is due to its stronger reducing 
capacity at acidic pH.34
3.7 | PPE1 and DOC affect Bet_v_1 processing and 
presentation in DCs
In order to test the relevance of the identified Bet_v_1 ligands in 
processing and presentation by DCs in a time‐dependent man‐
ner, we incubated BMDCs with Bet_v_1 in complex with different 
F I G U R E  1   Ligand interaction alters the proteolytic susceptibility of Bet_v_1. A, SDS‐PAGE analysis of in vitro endolysosomal degradation 
of Bet_v_1 with and without ligand recorded at different time points from 0 to 48 h and B, densitometric analysis thereof, interpreted 
with Image Lab 4.0.1 Software (Bio‐Rad). C, Generated peptide clusters obtained after 12 h of proteolytic degradation analyzed by mass 
spectrometry. D, The peptide sequences were grouped into seven degradation clusters with their relative abundance, as derived from MS 
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F I G U R E  2   Effect of ligands on Bet_v_1 degradation in vitro. A, Bet_v_1 degradation assay by cathepsin S and legumain in the absence 
or presence of various ligands. The degradation profile was analyzed by Coomassie Blue‐stained SDS‐PAGE and B, densitometric analysis. 
C, Bet_v_1 cleavage site frequency analyses of the degradation assay in (A). The analyses were based on the relative abundance of peptides 
measured by mass spectrometry, and the peptide intensity was normalized to the most abundant peptide found for the respective ligand. 
This is not a direct representation of the available cleavage sites, but rather emphasizes the varying kinetic accessibility of individual sites for 
one given ligand. The peptide profiles are presented in Figure S8
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ligands and detected the presentation of Bet_v_1 by using CD4+ T‐
cell hybridoma cells specific for the immune‐dominant T‐cell epitope 
(Thr142‐Ala153). T‐cell proliferation was monitored indirectly by 
IL‐2 secretion (Figure 5). Interestingly, Bet_v_1 in complex with PPE1 
consistently affected the MHCII presentation of Bet_v_1 epitope on 
DCs (Figure 5B‐F), whereas in complex with DOC epitope presenta‐
tion was affected only after 48 hours (Figure 5F). In contrast, Q3OS 
and PPB1 did not affect the presentation of Bet_v_1.
4  | DISCUSSION
Th2 polarization cannot be explained by allergenic proteins ex‐
clusively; instead, components of the pollen extract significantly 
contribute to the process of allergic sensitization.2 In this context, 
pollen‐derived compounds able to bind allergens represent promis‐
ing candidates in the search for additional factors complementing 
Bet_v_1 allergenicity.11,35‐39 Structurally, this property is encoded 
by Bet_v_1’s hydrophobic binding pocket, which can harbor com‐
pounds of up to 1400 Da.40,41 Here, for the first time, we observed 
that Bet_v_1 binds phytoprostanes, but not the TLR agonists LTA 
and LPS. The pollen‐derived ligands Q3OS and PPE1, as well as DOC, 
have micromolar affinities to Bet_v_1, comparable to previously 
published values for Q3OS and DOC.22,26
PPE1 inhibits the production of IL‐12p70 in LPS‐stimulated 
human DCs via blocking of NF‐κB and activation of PPAR‐γ, thus 
favoring a Th2‐dominated immune response.23,33 By contrast, we 
found that stimulation of moDCs by PPE1 in complex with Bet_v_1 
without additional LPS‐co‐stimulation did not upregulate maturation 
markers nor alter cytokine expression, neither did Bet_v_1 alone nor 
Bet_v_1 in complex with Q3OS or DOC. These discrepancies can be 
explained by the additional treatment with LPS, which via activation 
of TLR4 can induce expression of maturation markers.42
It has been suggested that diminished proteolytic processing 
of antigens results in low loading and density of class II MHC‐
peptide complexes, thus favoring Th2 polarization.18 Our results 
revealed that ligand binding resulted in an overall protein‐stabi‐
lizing effect. Increased thermal stability tended to correlate with 
proteolytic stability, which in turn affects immunogenicity/aller‐
genicity.17 Indeed, the susceptibility of Bet_v_1 to degradation by 
endolysosomal extracts was substantially reduced by the ligands 
DOC and PPE1. Due to its complexity, the reaction conditions 
of the endolysosomal fraction cannot be easily controlled, but 
its degradation pattern can largely be mimicked by cathepsin S, 
allowing us to establish an in vitro degradation system.21 Here, 
we revealed significant legumain activity as a component of the 
endolysosomal fraction, albeit with lower fluorescence signal. 
Consequently, legumain was included in the in vitro degradation 
system. Importantly, legumain is not a member of the papain‐like 
protease clan and therefore possesses mechanistic properties, 
substrate profiles, and inhibition profiles that are fundamentally 
different from cathepsins.29
Investigation using the in vitro degradation system revealed 
that Bet_v_1 ligands can tune Bet_v_1 endolysosomal processing 
in two mechanistically different ways. Firstly, ligands affected the 
allergen processing primarily with respect to the relative abun‐
dance of generated peptides available for MHC presentation. 
Secondly, the newly identified Bet_v_1 ligand PPE1 selectively in‐
hibited cathepsin S and other papain‐like cysteine proteases, but 
not legumain. Why PPE1, but not the two structurally related phy‐
toprostanes PPB1 and PPF1, possesses this inhibitory function can 
be explained by the chemical structure of PPE1, which differs from 
PPB1 and PPF1 at the five‐membered ring
43 (Figure 4C). The mech‐
anistic explanation for the cathepsin S‐inhibitory effect is that, 
under acidic conditions, PPE1 can spontaneously undergo dehy‐
dration,43 converting the five‐membered ring into an electrophilic 
F I G U R E  3   Effect of ligands and birch pollen extract (BPE) on cathepsin S and legumain activities. A, Effect of ligands on fluorogenic 
activity of lysosomal proteases. B, Effect of BPE on lysosomal protease activity. BPE was incubated with the respective protease, and the 
fluorogenic activity was measured after 15 min. Recombinant Bet_v_1 was used as control for a possible substrate competition effect. The 
percent fluorogenic activity was calculated over buffer control. Error bars indicate standard deviations
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Michael acceptor. The cyclopentenone favors the addition of the 
nucleophilic thiolate of the catalytic cysteine, thereby covalently 
blocking the protease active site (Figure 4E). The access to the 
active site of legumain is sterically more stringently controlled 
than the active site of papain‐like proteases,32 explaining why 
legumain neither reacts with nor is inhibited by PPE1. The reactive 
3‐hydroxy‐cyclopentanone is commonly found in plants44 and, 
in particular, was identified in birch pollen.9,45 PPE1 was found in 
plants at concentrations ranging from 4.5 to 61 ng per gram of dry 
weight.44
F I G U R E  4   Inhibition mechanism of PPE1. A, PPE1 inhibits papain‐like cysteine proteases, but not legumain. Papain‐like cysteine 
proteases (rat cathepsin B, cathepsin S, and papain) and legumain were incubated with PPE1 (5 µmol/L), and fluorogenic activities were 
recorded after 15 min. B, Effect of phytohormones (0.1 mmol/L) structurally related to PPE1 on cathepsin S activity. Fluorogenic activity 
was recorded after 15 min. C, Chemical structure of phytohormones used in (B). D, Effect of reducing agents on PPE1 inhibition of cathepsin 
S and legumain. The ability of proteases to cleave the fluorogenic substrates with and without PPE1 (5 µmol/L) in the presence of DTT 
and TCEP. Fluorogenic substrates used for cathepsin S and legumain were Z‐VVR‐AMC and Z‐AAN‐AMC, respectively. Error bars indicate 
standard deviations. Asterisk indicates statistical significance with P < 0.05. E, Proposed mechanism of cathepsin S inhibition by PPE1. PPE1 
undergoes spontaneous dehydration by β‐elimination, resulting in PPA1.
43 This reaction does not occur with PPB1, which lacks a hydroxyl 
group in the ring, and is disfavored in PPF1 due to the missing ketone group. The resulting PPA1 is an electrophile (Michael acceptor) and can 
be readily attacked by the nucleophilic cysteine of cathepsin S (Michael donor) at the β carbon to form a covalent adduct,48 thus inhibiting 
cathepsin S activity
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The immunological relevance of these unexpected findings was 
even demonstrated in a T‐cell proliferation assay, showing a unique 
reduction in the presentation of the T‐cell epitopes when Bet_v_1 
was complexed with PPE1. This drastic effect can mostly be explained 
by PPE1’s cysteine cathepsin‐inhibition function, and hardly to its sta‐
bilizing properties since such an effect was not observed for PPB1.
So far, it is unknown whether Bet_v_1 homologues from other 
pollen or food sources are able to bind ligands, which enables them 
to further increase their allergenicity in terms of proteolytic stabil‐
ity, processing, T‐cell proliferations, or IgE binding. Especially, in the 
light of the pollen‐food syndrome, future studies investigating ligand 
binding of clinically relevant Bet_v_1 homologues, such as Cor a 1, 
are required.46
To summarize, we identified an unexpected mechanism by which 
Bet_v_1 serves as a carrier of an endosomal inhibitor, which inter‐
feres with the main class of antigen‐processing proteases. Increased 
proteolytic resistance of Bet_v_1 drastically affects its allergenicity 
and immunogenicity.17 Furthermore, such broad‐spectrum inhibi‐
tion is likely to change not only the presented immunopeptidome 
but also the proteolytic activation of endosomal and intracellular 
immune receptors like TLRs and NLRs. Additionally, there may be 
a direct interaction of Bet_v_1 ligands with these receptors.47 The 
relevance of such direct or indirect activation by pollen‐derived non‐
proteinogenic molecules can help to reconcile the intriguing finding 
that the sensitization process by birch pollen extracts is independent 
from Bet_v_1.2
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